China Shineway Pharmaceutical (HKG:2877) profit for the year rose 13% to 949.9 million yuan for 2025, from 840.1 million yuan a year earlier, according to a Friday Hong Kong bourse filing.
Earnings per share came in at 1.26 yuan, compared with 1.11 yuan a year earlier.
Revenue fell 17% to 3.14 billion yuan from 3.78 billion yuan in 2024.
The company declared a first interim dividend of 0.43 yuan per share for 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.